FDA backs away from RFK Jr.’s claims about drug’s promise for autism patients
Policy

FDA backs away from RFK Jr.’s claims about drug’s promise for autism patients

The Food and Drug Administration does not have sufficient evidence to back the use of the generic drug leucovorin for …

0